Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23571)

Formulation Name
Tofacitinib Citrate eq 11mg base extended release tablet
Company
Pfizer
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Cellulose acetate E00702 Not Available Coating agent; Modified-release agent; Diluent
Copovidone E00693 Not Available Film/membrane-forming agent; Modified-release agent; Binding agent
Ferrosoferric oxide E00231 14789 Colorant
Haematite red E00236 14833 Colorant
Hydroxyethyl cellulose E00700 Not Available Coating agent; Suspending agent; Binding agent; Viscosity-controlling agent
Hydroxypropyl cellulose E00632 Not Available Binding agent; Coating agent; Emulsifying agent; Film/Membrane-forming agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Hypromellose E00634 Not Available Coating agent
Magnesium stearate E00208 11177 lubricant
Propylene glycol E00040 1030 Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Shellac E00695 Not Available Coating agent; Film/membrane-forming agent; Microencapsulating agent; Modified-release agent
Sorbitan tristearate E00516 17800859 Dispersing agent; Emulsifying agent; Solubilizing agent; Surfactant; Suspending agent; Vaccine adjuvant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Triacetin E00080 5541 Humectant; Plasticizing agent; Solvent